Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3G.

Stanley DJ, Bartholomeeusen K, Crosby DC, Kim DY, Kwon E, Yen L, Cartozo NC, Li M, Jäger S, Mason-Herr J, Hayashi F, Yokoyama S, Krogan NJ, Harris RS, Peterlin BM, Gross JD.

PLoS Pathog. 2012 Dec;8(12):e1003085. doi: 10.1371/journal.ppat.1003085. Epub 2012 Dec 27.

2.

Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.

Jäger S, Kim DY, Hultquist JF, Shindo K, LaRue RS, Kwon E, Li M, Anderson BD, Yen L, Stanley D, Mahon C, Kane J, Franks-Skiba K, Cimermancic P, Burlingame A, Sali A, Craik CS, Harris RS, Gross JD, Krogan NJ.

Nature. 2011 Dec 21;481(7381):371-5. doi: 10.1038/nature10693.

3.

T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.

Zhang W, Du J, Evans SL, Yu Y, Yu XF.

Nature. 2011 Dec 21;481(7381):376-9. doi: 10.1038/nature10718.

PMID:
22190036
4.

Characterization of MRFAP1 turnover and interactions downstream of the NEDD8 pathway.

Larance M, Kirkwood KJ, Xirodimas DP, Lundberg E, Uhlen M, Lamond AI.

Mol Cell Proteomics. 2012 Mar;11(3):M111.014407. doi: 10.1074/mcp.M111.014407. Epub 2011 Oct 29.

5.

Identification of an HIV-1 replication inhibitor which rescues host restriction factor APOBEC3G in Vif-APOBEC3G complex.

Zhang S, Zhong L, Chen B, Pan T, Zhang X, Liang L, Li Q, Zhang Z, Chen H, Zhou J, Luo H, Zhang H, Bai C.

Antiviral Res. 2015 Oct;122:20-7. doi: 10.1016/j.antiviral.2015.07.009. Epub 2015 Aug 1.

PMID:
26241003
6.

APOBEC3G is degraded by the proteasomal pathway in a Vif-dependent manner without being polyubiquitylated.

Dang Y, Siew LM, Zheng YH.

J Biol Chem. 2008 May 9;283(19):13124-31. doi: 10.1074/jbc.M708728200. Epub 2008 Mar 6.

7.

Biochemical and cellular effects of inhibiting Nedd8 conjugation.

Leck YC, Choo YY, Tan CY, Smith PG, Hagen T.

Biochem Biophys Res Commun. 2010 Jul 30;398(3):588-93. doi: 10.1016/j.bbrc.2010.06.128. Epub 2010 Jul 13.

PMID:
20603103
8.

ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction.

Miyakawa K, Matsunaga S, Kanou K, Matsuzawa A, Morishita R, Kudoh A, Shindo K, Yokoyama M, Sato H, Kimura H, Tamura T, Yamamoto N, Ichijo H, Takaori-Kondo A, Ryo A.

Nat Commun. 2015 Apr 22;6:6945. doi: 10.1038/ncomms7945.

9.

Moloney leukemia virus 10 (MOV10) inhibits the degradation of APOBEC3G through interference with the Vif-mediated ubiquitin-proteasome pathway.

Chen C, Ma X, Hu Q, Li X, Huang F, Zhang J, Pan T, Xia J, Liu C, Zhang H.

Retrovirology. 2017 Dec 19;14(1):56. doi: 10.1186/s12977-017-0382-1.

10.

The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation.

Donahue JP, Vetter ML, Mukhtar NA, D'Aquila RT.

Virology. 2008 Jul 20;377(1):49-53. doi: 10.1016/j.virol.2008.04.017. Epub 2008 May 21.

11.

Long-term passage of Vif-null HIV-1 in CD4+ T cells expressing sub-lethal levels of APOBEC proteins fails to develop APOBEC resistance.

Miyagi E, Kao S, Fumitaka M, Buckler-White A, Plishka R, Strebel K.

Virology. 2017 Apr;504:1-11. doi: 10.1016/j.virol.2017.01.016. Epub 2017 Jan 25.

12.

HIV-1 Vif-mediated ubiquitination/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain.

Iwatani Y, Chan DS, Liu L, Yoshii H, Shibata J, Yamamoto N, Levin JG, Gronenborn AM, Sugiura W.

Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19539-44. doi: 10.1073/pnas.0906652106. Epub 2009 Nov 3.

13.

Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.

Fribourgh JL, Nguyen HC, Wolfe LS, Dewitt DC, Zhang W, Yu XF, Rhoades E, Xiong Y.

J Virol. 2014 Mar;88(6):3309-19. doi: 10.1128/JVI.03824-13. Epub 2014 Jan 3.

14.

HIV relies on neddylation for ubiquitin ligase-mediated functions.

Nekorchuk MD, Sharifi HJ, Furuya AK, Jellinger R, de Noronha CM.

Retrovirology. 2013 Nov 18;10:138. doi: 10.1186/1742-4690-10-138.

15.

E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification.

Huang DT, Ayrault O, Hunt HW, Taherbhoy AM, Duda DM, Scott DC, Borg LA, Neale G, Murray PJ, Roussel MF, Schulman BA.

Mol Cell. 2009 Feb 27;33(4):483-95. doi: 10.1016/j.molcel.2009.01.011.

16.

MDM2 is a novel E3 ligase for HIV-1 Vif.

Izumi T, Takaori-Kondo A, Shirakawa K, Higashitsuji H, Itoh K, Io K, Matsui M, Iwai K, Kondoh H, Sato T, Tomonaga M, Ikeda S, Akari H, Koyanagi Y, Fujita J, Uchiyama T.

Retrovirology. 2009 Jan 7;6:1. doi: 10.1186/1742-4690-6-1.

17.

Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase.

Han X, Liang W, Hua D, Zhou X, Du J, Evans SL, Gao Q, Wang H, Viqueira R, Wei W, Zhang W, Yu XF.

J Virol. 2014 Mar;88(6):3320-8. doi: 10.1128/JVI.03833-13. Epub 2014 Jan 3.

18.

Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.

Zhang W, Wang H, Li Z, Liu X, Liu G, Harris RS, Yu XF.

J Virol. 2014 Nov;88(21):12528-40. doi: 10.1128/JVI.02072-14. Epub 2014 Aug 20.

19.

Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.

Refsland EW, Hultquist JF, Harris RS.

PLoS Pathog. 2012;8(7):e1002800. doi: 10.1371/journal.ppat.1002800. Epub 2012 Jul 12.

20.

Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.

Dang Y, Davis RW, York IA, Zheng YH.

J Virol. 2010 Jun;84(11):5741-50. doi: 10.1128/JVI.00079-10. Epub 2010 Mar 24.

Supplemental Content

Support Center